NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 42 filers reported holding NEON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,335,000 | +123.6% | 505,871 | 0.0% | 0.21% | +231.7% |
| Q4 2019 | $597,000 | -31.4% | 505,871 | 0.0% | 0.06% | -22.2% |
| Q3 2019 | $870,000 | -63.7% | 505,871 | 0.0% | 0.08% | -86.3% |
| Q2 2019 | $2,398,000 | -26.6% | 505,871 | 0.0% | 0.59% | -28.6% |
| Q1 2019 | $3,268,000 | +28.4% | 505,871 | 0.0% | 0.83% | +54.7% |
| Q4 2018 | $2,545,000 | -41.1% | 505,871 | 0.0% | 0.54% | -51.4% |
| Q3 2018 | $4,320,000 | -32.2% | 505,871 | 0.0% | 1.10% | -27.1% |
| Q2 2018 | $6,374,000 | – | 505,871 | – | 1.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 9,741,636 | $46,175,000 | 19.63% |
| Endurant Capital Management LP | 465,650 | $2,207,000 | 0.87% |
| HARVARD MANAGEMENT CO INC | 505,871 | $2,398,000 | 0.59% |
| Partner Investment Management, L.P. | 103,596 | $491,000 | 0.52% |
| MEITAV INVESTMENT HOUSE LTD | 639,465 | $3,002,000 | 0.20% |
| Hillhouse Capital Management | 399,308 | $1,893,000 | 0.06% |
| ArrowMark Colorado Holdings LLC | 703,375 | $3,334,000 | 0.03% |
| PFM Health Sciences, LP | 121,848 | $578,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,200 | $755,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 77,024 | $365,000 | 0.01% |